Literature DB >> 24626604

Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Susan W Volk1, Shalin R Shah, Arthur J Cohen, Yanjian Wang, Becky K Brisson, Laurie K Vogel, Kurt D Hankenson, Sherrill L Adams.   

Abstract

Type III collagen (Col3), a fibril-forming collagen, is a major extracellular matrix component in a variety of internal organs and skin. It is also expressed at high levels during embryonic skeletal development and is expressed by osteoblasts in mature bone. Loss of function mutations in the gene encoding Col3 (Col3a1) are associated with vascular Ehlers-Danlos syndrome (EDS). Although the most significant clinical consequences of this syndrome are associated with catastrophic failure and impaired healing of soft tissues, several studies have documented skeletal abnormalities in vascular EDS patients. However, there are no reports of the role of Col3 deficiency on the murine skeleton. We compared craniofacial and skeletal phenotypes in young (6-8 weeks) and middle-aged (>1 year) control (Col3(+/+)) and haploinsufficient (Col3(+/-)) mice, as well as young null (Col3(-/-)) mice by microcomputed tomography (μCT). Although Col3(+/-) mice did not have significant craniofacial abnormalities based upon cranial morphometrics, μCT analysis of distal femur trabecular bone demonstrated significant reductions in bone volume (BV), bone volume fraction (BV/TV), connectivity density, structure model index and trabecular thickness in young adult female Col3(+/-) mice relative to wild-type littermates. The reduction in BV/TV persisted in female mice at 1 year of age. Next, we evaluated the role of Col3 in vitro. Osteogenesis assays revealed that cultures of mesenchymal progenitors collected from Col3(-/-) embryos display decreased alkaline phosphatase activity and reduced capacity to undergo mineralization. Consistent with this data, a reduction in expression of osteogenic markers (type I collagen, osteocalcin and bone sialoprotein) correlates with reduced bone Col3 expression in Col3(+/-) mice and with age in vivo. A small but significant reduction in osteoclast numbers was found in Col3(+/-) compared to Col3(+/+) bones. Taken together, these findings indicate that Col3 plays a role in development of trabecular bone through its effects on osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24626604      PMCID: PMC4335719          DOI: 10.1007/s00223-014-9843-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  54 in total

1.  Type I and type III collagen content of healing wounds in fetal and adult rats.

Authors:  J R Merkel; B R DiPaolo; G G Hallock; D C Rice
Journal:  Proc Soc Exp Biol Med       Date:  1988-04

2.  Covalent crosslinking between molecules of type I and type III collagen. The involvement of the N-terminal, nonhelical regions of the alpha 1 (I) and alpha 1 (III) chains in the formation of intermolecular crosslinks.

Authors:  W Henkel; R W Glanville
Journal:  Eur J Biochem       Date:  1982-02

3.  Presence of type III collagen in bone from a patient with osteogenesis imperfecta.

Authors:  P K Müller; K Raisch; K Matzen; S Gay
Journal:  Eur J Pediatr       Date:  1977-04-26       Impact factor: 3.183

4.  Structure of the dermal matrix during development and in the adult.

Authors:  L T Smith; K A Holbrook; P H Byers
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

5.  Procollagen messenger RNA levels and activity and collagen synthesis during the fetal development of sheep lung, tendon, and skin.

Authors:  P Tolstoshev; R Haber; B C Trapnell; R G Crystal
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

6.  Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis.

Authors:  M Apaja-Sarkkinen; H Autio-Harmainen; M Alavaikko; J Risteli; L Risteli
Journal:  Br J Haematol       Date:  1986-07       Impact factor: 6.998

7.  Transitions in collagen types during matrix-induced cartilage, bone, and bone marrow formation.

Authors:  A H Reddi; R Gay; S Gay; E J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Immunohistochemical distribution of collagens types IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentine.

Authors:  J Becker; D Schuppan; H Benzian; T Bals; E G Hahn; C Cantaluppi; P Reichart
Journal:  J Histochem Cytochem       Date:  1986-11       Impact factor: 2.479

9.  Distribution of fibronectin and collagen during mouse limb and palate development.

Authors:  M H Silver; J M Foidart; R M Pratt
Journal:  Differentiation       Date:  1981       Impact factor: 3.880

10.  Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.

Authors:  D R Keene; L Y Sakai; H P Bächinger; R E Burgeson
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  25 in total

1.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

2.  Bone involvement in adult patients affected with Ehlers-Danlos syndrome.

Authors:  C Eller-Vainicher; A Bassotti; A Imeraj; E Cairoli; F M Ulivieri; F Cortini; M Dubini; B Marinelli; A Spada; I Chiodini
Journal:  Osteoporos Int       Date:  2016-04-15       Impact factor: 4.507

Review 3.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

4.  Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer.

Authors:  Becky K Brisson; Elizabeth A Mauldin; Weiwei Lei; Laurie K Vogel; Ashley M Power; Albert Lo; Derek Dopkin; Chand Khanna; Rebecca G Wells; Ellen Puré; Susan W Volk
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

Review 5.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

6.  Type III collagen is a key regulator of the collagen fibrillar structure and biomechanics of articular cartilage and meniscus.

Authors:  Chao Wang; Becky K Brisson; Masahiko Terajima; Qing Li; Kevt'her Hoxha; Biao Han; Abby M Goldberg; X Sherry Liu; Michele S Marcolongo; Motomi Enomoto-Iwamoto; Mitsuo Yamauchi; Susan W Volk; Lin Han
Journal:  Matrix Biol       Date:  2019-10-23       Impact factor: 11.583

Review 7.  Bone physiology as inspiration for tissue regenerative therapies.

Authors:  Diana Lopes; Cláudia Martins-Cruz; Mariana B Oliveira; João F Mano
Journal:  Biomaterials       Date:  2018-09-17       Impact factor: 12.479

8.  Restoring extracellular matrix synthesis in senescent stem cells.

Authors:  Na Rong; Panagiotis Mistriotis; Xiaoyan Wang; Georgios Tseropoulos; Nika Rajabian; Yali Zhang; Jianmin Wang; Song Liu; Stelios T Andreadis
Journal:  FASEB J       Date:  2019-07-09       Impact factor: 5.834

9.  Cysteine-rich domain of type III collagen N-propeptide inhibits fibroblast activation by attenuating TGFβ signaling.

Authors:  Becky K Brisson; Daniel C Stewart; Chelsea Burgwin; David Chenoweth; Rebecca G Wells; Sherrill L Adams; Susan W Volk
Journal:  Matrix Biol       Date:  2022-03-24       Impact factor: 10.447

10.  Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?

Authors:  Alba Murgia; Elena Veronesi; Olivia Candini; Anna Caselli; Naomi D'souza; Valeria Rasini; Andrea Giorgini; Fabio Catani; Lorenzo Iughetti; Massimo Dominici; Jorge S Burns
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.